| Dealing with schistosomiasis: Current drug discovery strategies |
4 |
| Drugs and Drug Resistance in African and American Trypanosomiasis |
3 |
| X-ray Crystallography Contributions to Drug Discovery Against Parasite |
2 |
| Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules |
2 |
| Development of MmpL3 inhibitors for tuberculosis treatment |
1 |
| Inhibitors of enzymes in the electron transport chain of Mycobacterium tuberculosis |
1 |
| A decade of malaria phenotypic screenings: Key lessons on the discovery and development of new antimalarial drugs |
1 |
| The hybrid antimalarial approach |
1 |
| Targeting Human Onchocerciasis: Recent Advances Beyond Ivermectin |
1 |
| Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis |
1 |
| Multicomponent reactions: A mighty journey partner for infectious tropical disease drug discovery |
0 |
| Shortcuts to schistosomiasis drug discovery: The state-of-the-art |
0 |
| Medicinal chemistry progression of antimalarial hits from phenotypic whole cell screening of SoftFocus libraries |
0 |
| Antituberculosis agents: Beyond medicinal chemistry rules |
0 |
| Sustainable anti-trypanosomatid drugs: An aspirational goal for medicinal chemistry |
0 |
| Recent advances in the design of inhibitors of mycobacterial transcriptional regulators to boost thioamides anti-tubercular activity and circumvent acquired-resistance |
0 |
| Tuberculosis |
0 |
